Key Takeaway: The article discusses a study on predicting human pharmacokinetic profiles of Glyph platform prodrugs. It utilizes both animal and human data through a semi-mechanistic pharmacokinetic model. This research aims to enhance the understanding of drug behavior in humans based on prior animal studies.
Price reaction · baseline $17.44 (2026-06-15 close) · hit pre-market · 1 other SPTX headline(s) in the window, move may be shared
day 0 close · peak
+3%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Cash runway
~12 mo
Low dilution risk
Lead asset
SPT-300
Phase 2 · Major Depressive Disorder (MDD)
Full Press Release Details
Home
Pipeline
Team
Research
NEWS
INVESTORS
Careers
Contact
Array - June 16, 2026
Prediction of Human Pharmacokinetic Profiles of Glyph Platform Prodrugs Using Animal and Human Data via a Semi-mechanistic Pharmacokinetic Model